Thats odd, I would think they would want to make sure groups are balanced for T2D at the start to avoid questions about one trial have an overwhelmingly large amount of T2D patients biasing results
Select GLP-1based therapies are FDA-approved for chronic weight management and have been shown to be safe and effective for individuals who meet clinical criteria
For the 2.5 mg starting dose, you need 50 units (0.5 mL)
Wegovy and Injection Site Reactions: What Patients Are Saying For most people, starting Wegovy (semaglutide) comes with clear expectations: reduced appetite, potential weight loss, and some nausea along the way
Animal studies have revealed evidence of embryofetal mortality, early pregnancy losses, structural abnormalities, and growth alterations
How Semaglutide Changes Your Eating Patterns Semaglutide works by slowing digestion, reducing appetite, and improving blood-sugar regulation